← Browse by Condition
Medical Condition

transthyretin amyloid cardiomyopathy attr cm

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT07207811 Phase 3
Recruiting

CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

Enrollment
1,280 pts
Location
United States, Argen...
Sponsor
Novo Nordisk A/S
View Trial →